Drug Profile
Research programme: anticancer therapeutics - LegoChem Biosciences/Newgex
Alternative Names: I HSP90 (1) - LegoChem; I HSP90 (2) - LegoChemLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator LegoChem Biosciences; Newgex
- Developer LegoChem Biosciences
- Class
- Mechanism of Action HSP90 heat-shock protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in South Korea